Molecular Medicine · 2000 · 36 citations · 29 references
Life SciencesGeneticsMolecular GeneticsDevelopmental GeneticsMedical GeneticsTransgenic Animal ModelsCongenital Skin DisordersFibrosisGenetic DisordersGenetic SyndromesMutationPlasmid VectorsSkin Fibrosis
BACKGROUND: Tight skin mice (TSK) bear a mutated Fibrillin-1 (Fbn-1) gene. Genetic studies show that the TSK mutation is closely associated with the Fbn-1 locus (0-0.7 cM). A previous study showed two recombinants between the Fbn-1 locus and the TSK mutation. TSK mutation and mutated Fbn-1 gene cosegregate in F1 mice. MATERIALS AND METHODS: To elucidate the role of the mutated Fbn-1 gene in occurrence of TSK syndrome, we generated transgenic (Tg) mice expressing mutated Fbn-1 gene. In another set of experiments, we injected normal mice after birth with a plasmid bearing mutated Fbn-1 gene (pdFbn-1). RESULTS: Our results demonstrate that the pdFbn-1 Tg mice developed permanent cutaneous hyperplasia that was permanent. In mice injected as newborns with a plasmid bearing the sense pdFbn-1 gene, cutaneous hyperplasia was transient. In contrast to TSK mice, neither Tg nor mice injected with plasmid developed lung emphysema. The pdFbn-1 Tg and TSK mice spontaneously produced anti-topoisomerase I and anti-Fbn- antibodies, as do humans afflicted by scleroderma; whereas, those injected with a plasmid containing the pdFbn-1 gene produced only anti-Fbn-1 autoantibodies. CONCLUSIONS: The results suggest that, although cutaneous hyperplasia is due to mutated Fbn-1 gene, the TSK syndrome may be multifactorial.
29
Direct Gene Transfer into Mouse Muscle in Vivo
Jon A. Wolff, Robert W. Malone, Phillip Williams et al. · Science · 1990 · 4.2K citations
Sofía Casares, Kayo Inaba, Teodor-Doru Brumeanu et al. · The Journal of Experimental Medicine · 1997 · 320 citations · Full text
High Titers of Autoantibodies to Topoisomerase I (Scl-70) in Sera from Scleroderma Patients
J. H. Shero, Bonnie J. Bordwell, N Rothfield et al. · Science · 1986 · 308 citations